SK13622000A3 - Kryštalická forma paroxetínu, farmaceutický prostriedok a použitie - Google Patents

Kryštalická forma paroxetínu, farmaceutický prostriedok a použitie Download PDF

Info

Publication number
SK13622000A3
SK13622000A3 SK1362-2000A SK13622000A SK13622000A3 SK 13622000 A3 SK13622000 A3 SK 13622000A3 SK 13622000 A SK13622000 A SK 13622000A SK 13622000 A3 SK13622000 A3 SK 13622000A3
Authority
SK
Slovakia
Prior art keywords
paroxetine
free base
paroxetine free
product
crystalline
Prior art date
Application number
SK1362-2000A
Other languages
English (en)
Slovak (sk)
Inventor
Andrew Simon Craig
Neal Ward
Wilson Mcilwaine
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9805581.7A external-priority patent/GB9805581D0/en
Priority claimed from GBGB9813054.5A external-priority patent/GB9813054D0/en
Priority claimed from GBGB9817115.0A external-priority patent/GB9817115D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of SK13622000A3 publication Critical patent/SK13622000A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK1362-2000A 1998-03-16 1999-03-16 Kryštalická forma paroxetínu, farmaceutický prostriedok a použitie SK13622000A3 (sk)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9805581.7A GB9805581D0 (en) 1998-03-16 1998-03-16 Novel compounds
GBGB9813054.5A GB9813054D0 (en) 1998-06-17 1998-06-17 Novel compounds
GBGB9817115.0A GB9817115D0 (en) 1998-08-06 1998-08-06 Novel compounds
PCT/GB1999/000793 WO1999047519A1 (en) 1998-03-16 1999-03-16 Crystalline form of paroxetine

Publications (1)

Publication Number Publication Date
SK13622000A3 true SK13622000A3 (sk) 2001-03-12

Family

ID=27269245

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1362-2000A SK13622000A3 (sk) 1998-03-16 1999-03-16 Kryštalická forma paroxetínu, farmaceutický prostriedok a použitie

Country Status (18)

Country Link
EP (1) EP1064282A1 (ru)
JP (1) JP2002506865A (ru)
KR (1) KR20010041947A (ru)
CN (1) CN1300286A (ru)
AP (1) AP2000001907A0 (ru)
AU (1) AU2847199A (ru)
BG (1) BG104839A (ru)
BR (1) BR9908825A (ru)
CA (1) CA2323896A1 (ru)
EA (1) EA200000946A1 (ru)
HU (1) HUP0101215A3 (ru)
ID (1) ID27596A (ru)
IL (1) IL138390A0 (ru)
NO (1) NO20004583L (ru)
PL (1) PL342931A1 (ru)
SK (1) SK13622000A3 (ru)
TR (1) TR200002675T2 (ru)
WO (1) WO1999047519A1 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
GB9919052D0 (en) * 1999-08-12 1999-10-13 Smithkline Beecham Plc Novel compound composition and process
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
ES2058061T3 (es) * 1985-10-25 1994-11-01 Beecham Group Plc Derivado de piperidina, su preparacion y su uso como medicamento.
SK283608B6 (sk) * 1995-02-06 2003-10-07 Smithkline Beecham Plc Bezvodý hydrochlorid paroxetínu, spôsob jeho výroby a použitie

Also Published As

Publication number Publication date
ID27596A (id) 2001-04-12
EA200000946A1 (ru) 2001-02-26
HUP0101215A2 (hu) 2002-04-29
HUP0101215A3 (en) 2002-05-28
BG104839A (en) 2001-09-28
KR20010041947A (ko) 2001-05-25
AU2847199A (en) 1999-10-11
CA2323896A1 (en) 1999-09-23
IL138390A0 (en) 2001-10-31
TR200002675T2 (tr) 2000-12-21
BR9908825A (pt) 2000-11-21
PL342931A1 (en) 2001-07-16
WO1999047519A1 (en) 1999-09-23
JP2002506865A (ja) 2002-03-05
CN1300286A (zh) 2001-06-20
NO20004583L (no) 2000-09-15
NO20004583D0 (no) 2000-09-14
EP1064282A1 (en) 2001-01-03
AP2000001907A0 (en) 2000-09-30

Similar Documents

Publication Publication Date Title
EP0808314B1 (en) Forms of paroxetin hydrochloride
US6080759A (en) Paroxetine hydrochloride form A
EA025438B1 (ru) КРИСТАЛЛИЧЕСКИЙ КОМПЛЕКС 1-ЦИАНО-2-(4-ЦИКЛОПРОПИЛБЕНЗИЛ)-4-(β-D-ГЛЮКОПИРАНОЗ-1-ИЛ)БЕНЗОЛА, СПОСОБЫ ЕГО ПОЛУЧЕНИЯ И ЕГО ПРИМЕНЕНИЕ ДЛЯ ПРИГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ
US20060189675A1 (en) Crystalline form of a drug
US20070123582A1 (en) Crystalline form of a drug
WO2000035910A1 (en) Derivative of paroxetine
WO2000035873A1 (en) Process for preparation of paroxetine maleate
SK13622000A3 (sk) Kryštalická forma paroxetínu, farmaceutický prostriedok a použitie
RU2177478C2 (ru) Безводная кристаллическая форма гидрохлорида r(-)-n-(4,4-ди (3-метилтиен -2-ил) бут-3-енил)-нипекотиновой кислоты, способ ее получения, фармацевтическая композиция и способ лечения
CA2327450A1 (en) Paroxetine maleate
EP1135382A1 (en) Method of producing paroxetine hydrochloride
CZ20003343A3 (cs) Krystalická forma paroxetinu
MXPA00009137A (es) Forma cristalina de paroxetina
US20020137938A1 (en) Novel process
WO2000032595A1 (en) Process for the production of paroxetine hydrochloride acetone solvate
WO2001012623A1 (en) Process for the preparation of paroxetine hydrochloride
EP1408039A2 (en) Mixed paraxetine propan-2-ol solvates
WO2000008016A1 (en) Paroxetine salts
US20030028027A1 (en) Paroxetine maleate
WO2001025201A1 (en) Process for the preparation of paroxetin intermediate
WO2000032596A1 (en) Amine salts of paroxetine
EP1133492A1 (en) Process for the preparation of paroxetine hydrochloride
US20010008940A1 (en) Novel process
EP1178962A1 (en) Process for the preparation of paroxetine acetate and analogues thereof
WO2001029002A1 (en) Process for the preparation of 4-(fluorophenyl)piperidine esters